-
1
-
-
84925862164
-
Cumulative life course impairment: Evidence for psoriasis
-
[PMID:23796812]
-
Mattei PL, Corey KC, Kimball AB. Cumulative life course impairment: evidence for psoriasis. Curr Probl Dermatol. 2013;44:82-90. [PMID:23796812]
-
(2013)
Curr Probl Dermatol
, vol.44
, pp. 82-90
-
-
Mattei, P.L.1
Corey, K.C.2
Kimball, A.B.3
-
3
-
-
84886876515
-
Quality-of-life effects of common dermatological diseases
-
[PMID:24049968]
-
Ahmed A, Leon A, Butler DC, Reichenberg J. Quality-of-life effects of common dermatological diseases. Semin Cutan Med Surg. 2013;32(2):101-9. [PMID:24049968]
-
(2013)
Semin Cutan Med Surg
, vol.32
, Issue.2
, pp. 101-109
-
-
Ahmed, A.1
Leon, A.2
Butler, D.C.3
Reichenberg, J.4
-
4
-
-
0032872277
-
Psoriasis causes as much disability as other major medical diseases
-
[PMID:10459113]
-
Rapp SR, Feldman SR, Exum ML, Fleischer AB, Jr., Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;41(3 Pt 1):401-7. [PMID:10459113]
-
(1999)
J Am Acad Dermatol
, vol.41
, Issue.3 PART 1
, pp. 401-407
-
-
Rapp, S.R.1
Feldman, S.R.2
Exum, M.L.3
Fleischer Jr., A.B.4
Reboussin, D.M.5
-
5
-
-
84880329838
-
A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions
-
[PMID:23207011]
-
Bhutani T, Patel T, Koo B, Nguyen T, Hong J, Koo J. A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions. J Am Acad Dermatol. 2013;69(2):e79-88. [PMID:23207011]
-
(2013)
J Am Acad Dermatol
, vol.69
, Issue.2
-
-
Bhutani, T.1
Patel, T.2
Koo, B.3
Nguyen, T.4
Hong, J.5
Koo, J.6
-
6
-
-
20444502501
-
Involving the patient: Impact of inflammatory skin disease and patient-focused care
-
[PMID:15968267]
-
Feldman S, Behnam SM, Behnam SE, Koo JY. Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol. 2005;53(1 Suppl 1)S78-85. [PMID:15968267]
-
(2005)
J Am Acad Dermatol
, vol.53
, Issue.1 SUPPL. 1
-
-
Feldman, S.1
Behnam, S.M.2
Behnam, S.E.3
Koo, J.Y.4
-
7
-
-
31144475609
-
The psychosocial burden of psoriasis
-
[PMID:16343026]
-
Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383-92. [PMID:16343026]
-
(2005)
Am J Clin Dermatol
, vol.6
, Issue.6
, pp. 383-392
-
-
Kimball, A.B.1
Jacobson, C.2
Weiss, S.3
Vreeland, M.G.4
Wu, Y.5
-
8
-
-
83655172559
-
A roadmap for improving healthcare service quality
-
[PMID:22201201]
-
Kennedy DM, Caselli RJ, Berry LL. A roadmap for improving healthcare service quality. J Healthc Manag. 2011;56(6):385-400. [PMID:22201201]
-
(2011)
J Healthc Manag
, vol.56
, Issue.6
, pp. 385-400
-
-
Kennedy, D.M.1
Caselli, R.J.2
Berry, L.L.3
-
9
-
-
21044440425
-
Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: A double-blind placebo-controlled trial
-
[PMID:15888152]
-
Feldman SR, Gordon KB, Bala M, Evans R, Li S, Dooley LT, Guzzo C, Patel K, Menter A, Gottlieb AB. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial. Br J Dermatol. 2005;152(5):954-60. [PMID:15888152]
-
(2005)
Br J Dermatol
, vol.152
, Issue.5
, pp. 954-960
-
-
Feldman, S.R.1
Gordon, K.B.2
Bala, M.3
Evans, R.4
Li, S.5
Dooley, L.T.6
Guzzo, C.7
Patel, K.8
Menter, A.9
Gottlieb, A.B.10
-
10
-
-
79959816954
-
Impact of ustekinumab on healthrelated quality of life and sexual difficulties associated with psoriasis: Results from two phase III clinical trials
-
[PMID:21521375]
-
Guenther L, Han C, Szapary P, Schenkel B, Poulin Y, Bourcier M, Ortonne JP, Sofen HL. Impact of ustekinumab on healthrelated quality of life and sexual difficulties associated with psoriasis: results from two phase III clinical trials. J Eur Acad Dermatol Venereol. 2011;25(7):851-7. [PMID:21521375]
-
(2011)
J Eur Acad Dermatol Venereol
, vol.25
, Issue.7
, pp. 851-857
-
-
Guenther, L.1
Han, C.2
Szapary, P.3
Schenkel, B.4
Poulin, Y.5
Bourcier, M.6
Ortonne, J.P.7
Sofen, H.L.8
-
11
-
-
84855231275
-
Patients with psoriasis feel stigmatized
-
[PMID:21879243]
-
Hrehorów E, Salomon J, Matusiak L, Reich A, Szepietowski JC. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92(1):67-72. [PMID:21879243]
-
(2012)
Acta Derm Venereol
, vol.92
, Issue.1
, pp. 67-72
-
-
Hrehorów, E.1
Salomon, J.2
Matusiak, L.3
Reich, A.4
Szepietowski, J.C.5
-
12
-
-
0032085771
-
Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: An index of the stigma experience in dermatologic disorders
-
[PMID:9640555]
-
Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis. 1998;61(6):339-42. [PMID:9640555]
-
(1998)
Cutis
, vol.61
, Issue.6
, pp. 339-342
-
-
Gupta, M.A.1
Gupta, A.K.2
Watteel, G.N.3
-
13
-
-
18744406706
-
The psychological and social burdens of psoriasis
-
[PMID:15782923]
-
Young M. The psychological and social burdens of psoriasis. Dermatol Nurs. 2005;17(1):15-9. [PMID:15782923]
-
(2005)
Dermatol Nurs
, vol.17
, Issue.1
, pp. 15-19
-
-
Young, M.1
-
14
-
-
0027320785
-
Psychosocial consequences of rejection and stigma feelings in psoriasis patients
-
[PMID:8407075]
-
Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol. 1993;32(8):587-91. [PMID:8407075]
-
(1993)
Int J Dermatol
, vol.32
, Issue.8
, pp. 587-591
-
-
Ginsburg, I.H.1
Link, B.G.2
-
15
-
-
79957601283
-
Quality of life and sexual health in patients with genital psoriasis
-
[PMID:21332459]
-
Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, Evers AW, Massuger LF, van de Kerkhof P.C, van Rossum MM. Quality of life and sexual health in patients with genital psoriasis. Br J Dermatol. 2011;164(6):1247-55. [PMID:21332459]
-
(2011)
Br J Dermatol
, vol.164
, Issue.6
, pp. 1247-1255
-
-
Meeuwis, K.A.1
de Hullu, J.A.2
van de Nieuwenhof, H.P.3
Evers, A.W.4
Massuger, L.F.5
van de Kerkhof, P.C.6
van Rossum, M.M.7
-
16
-
-
77955134594
-
Sex and the skin: A qualitative study of patients with acne, psoriasis and atopic eczema
-
[PMID:20677083]
-
Magin P, Heading G, Adams J, Pond D. Sex and the skin: a qualitative study of patients with acne, psoriasis and atopic eczema. Psychol Health Med. 2010;15(4):454-62. [PMID:20677083]
-
(2010)
Psychol Health Med
, vol.15
, Issue.4
, pp. 454-462
-
-
Magin, P.1
Heading, G.2
Adams, J.3
Pond, D.4
-
17
-
-
84906254283
-
Impact of psoriasis on sexual activity
-
Available at, Accessed January 30, 2014
-
Splete H. Impact of psoriasis on sexual activity. Skin & Allergy News. 2013. Available at: http://www.skinandallergynews.com/index.php?id=159&tx_ttnews%5Btt_news%5D=223073&cHash=5d1771b5739545e6e7 17000274d012d0. Accessed January 30, 2014.
-
(2013)
Skin & Allergy News
-
-
Splete, H.1
-
18
-
-
0028918535
-
The effect of severe psoriasis on the quality of life of 369 patients
-
[PMID:7888360]
-
Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 1995;132(2):236-44. [PMID:7888360]
-
(1995)
Br J Dermatol
, vol.132
, Issue.2
, pp. 236-244
-
-
Finlay, A.Y.1
Coles, E.C.2
-
19
-
-
0035069606
-
The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey
-
[PMID:11255325]
-
Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001;137(3):280-4. [PMID:11255325]
-
(2001)
Arch Dermatol
, vol.137
, Issue.3
, pp. 280-284
-
-
Krueger, G.1
Koo, J.2
Lebwohl, M.3
Menter, A.4
Stern, R.S.5
Rolstad, T.6
-
20
-
-
32644473642
-
The negative impact of psoriasis on the workplace
-
[PMID:16467020]
-
Pearce DJ, Singh S, Balkrishnan R, Kulkarni A, Fleischer AB, Feldman SR. The negative impact of psoriasis on the workplace. J Dermatolog Treat. 2006;17(1):24-8. [PMID:16467020]
-
(2006)
J Dermatolog Treat
, vol.17
, Issue.1
, pp. 24-28
-
-
Pearce, D.J.1
Singh, S.2
Balkrishnan, R.3
Kulkarni, A.4
Fleischer, A.B.5
Feldman, S.R.6
-
21
-
-
33747081908
-
Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis
-
[PMID:16902286]
-
Schmitt JM, Ford DE. Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology. 2006;213(2):102-10. [PMID:16902286]
-
(2006)
Dermatology
, vol.213
, Issue.2
, pp. 102-110
-
-
Schmitt, J.M.1
Ford, D.E.2
-
22
-
-
36049047981
-
Association of patient-reported psoriasis severity with income and employment
-
[PMID:17761358]
-
Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol. 2007;57(6):963-71. [PMID:17761358]
-
(2007)
J Am Acad Dermatol
, vol.57
, Issue.6
, pp. 963-971
-
-
Horn, E.J.1
Fox, K.M.2
Patel, V.3
Chiou, C.F.4
Dann, F.5
Lebwohl, M.6
-
23
-
-
40349095005
-
The psychosocial and occupational impact of chronic skin disease
-
[PMID:18318886]
-
Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21(1):54-9. [PMID:18318886]
-
(2008)
Dermatol Ther
, vol.21
, Issue.1
, pp. 54-59
-
-
Hong, J.1
Koo, B.2
Koo, J.3
-
24
-
-
84856245789
-
Quality-of-life instruments: Evaluation of the impact of psoriasis on patients
-
[PMID:22284142]
-
Heller MM, Wong JW, Nguyen TV, Lee ES, Bhutani T, Menter A, Koo JY. Quality-of-life instruments: evaluation of the impact of psoriasis on patients. Dermatol Clin. 2012;30(2):281-91. [PMID:22284142]
-
(2012)
Dermatol Clin
, vol.30
, Issue.2
, pp. 281-291
-
-
Heller, M.M.1
Wong, J.W.2
Nguyen, T.V.3
Lee, E.S.4
Bhutani, T.5
Menter, A.6
Koo, J.Y.7
-
25
-
-
84900824464
-
The Psoriasis Symptom Diary: Development and content validity of a novel patient-reported outcome instrument
-
doi: 10.1111/j.365-4632.2012.05798.x. [Epub ahead of print]. [PMID:23557000]
-
Lebwohl M, Swensen AR, Nyirady J, Kim E, Gwaltney CJ, Strober BE. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument. Int J Dermatol. 2013 doi: 10.1111/j.365-4632.2012.05798.x. [Epub ahead of print]. [PMID:23557000]
-
(2013)
Int J Dermatol
-
-
Lebwohl, M.1
Swensen, A.R.2
Nyirady, J.3
Kim, E.4
Gwaltney, C.J.5
Strober, B.E.6
-
26
-
-
20444466784
-
Decision points for the initiation of systemic treatment for psoriasis
-
[PMID:15965429]
-
Feldman SR, Koo JY, Menter A, Bagel J. Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol. 2005;53(1):101-7. [PMID:15965429]
-
(2005)
J Am Acad Dermatol
, vol.53
, Issue.1
, pp. 101-107
-
-
Feldman, S.R.1
Koo, J.Y.2
Menter, A.3
Bagel, J.4
-
27
-
-
28844490562
-
Patient-reported outcomes of psoriasis improvement with etanercept therapy: Results of a randomized phase III trial
-
[PMID:16307657]
-
Krueger GG, Langley RG, Finlay AY, Griffiths CE, Woolley JM, Lalla D, Jahreis A. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. Br J Dermatol. 2005;153(6):1192-9. [PMID:16307657]
-
(2005)
Br J Dermatol
, vol.153
, Issue.6
, pp. 1192-1199
-
-
Krueger, G.G.1
Langley, R.G.2
Finlay, A.Y.3
Griffiths, C.E.4
Woolley, J.M.5
Lalla, D.6
Jahreis, A.7
-
28
-
-
33646547957
-
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: A randomized controlled trial
-
[PMID:16704649]
-
Reich K, Nestle FO, Papp K, Ortonne JP, Wu Y, Bala M, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial. Br J Dermatol. 2006;154(6):1161-8. [PMID:16704649]
-
(2006)
Br J Dermatol
, vol.154
, Issue.6
, pp. 1161-1168
-
-
Reich, K.1
Nestle, F.O.2
Papp, K.3
Ortonne, J.P.4
Wu, Y.5
Bala, M.6
Evans, R.7
Guzzo, C.8
Li, S.9
Dooley, L.T.10
Griffiths, C.E.11
-
29
-
-
36849070806
-
Impact of adalimumab treatment on patient-reported outcomes: Results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis
-
[PMID:18058494]
-
Revicki DA, Willian MK, Menter A, Gordon KB, Kimball AB, Leonardi CL, Langley RG, Kimel M, Okun M. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis. J Dermatolog Treat. 2007;18(6):341-50. [PMID:18058494]
-
(2007)
J Dermatolog Treat
, vol.18
, Issue.6
, pp. 341-350
-
-
Revicki, D.A.1
Willian, M.K.2
Menter, A.3
Gordon, K.B.4
Kimball, A.B.5
Leonardi, C.L.6
Langley, R.G.7
Kimel, M.8
Okun, M.9
-
30
-
-
70350336843
-
Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis
-
[PMID:19752505]
-
Reich K, Segaert S, van de Kerkhof P, Durian C, Boussuge MP, Paolozzi L, Wajdula J, Boggs R. Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. Dermatology. 2009;219(3):239-49. [PMID:19752505]
-
(2009)
Dermatology
, vol.219
, Issue.3
, pp. 239-249
-
-
Reich, K.1
Segaert, S.2
van de Kerkhof, P.3
Durian, C.4
Boussuge, M.P.5
Paolozzi, L.6
Wajdula, J.7
Boggs, R.8
-
31
-
-
84865634236
-
Japanese Ustekinumab Study G. Impact of ustekinumab on healthrelated quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2/3 trial
-
[PMID:22409383]
-
Nakagawa H, Schenkel B, Kato M, Kato T, Igarashi A, Japanese Ustekinumab Study G. Impact of ustekinumab on healthrelated quality of life in Japanese patients with moderate-to-severe plaque psoriasis: results from a randomized, double-blind, placebo-controlled phase 2/3 trial. J Dermatol. 2012;39(9):761-9. [PMID:22409383]
-
(2012)
J Dermatol
, vol.39
, Issue.9
, pp. 761-769
-
-
Nakagawa, H.1
Schenkel, B.2
Kato, M.3
Kato, T.4
Igarashi, A.5
-
32
-
-
84879751896
-
Impact of TNF-α antagonists on the quality of life in selected skin diseases
-
[PMID:23670060]
-
Gisondi P, Girolomoni G. Impact of TNF-α antagonists on the quality of life in selected skin diseases. G Ital Dermatol Venereol. 2013;148(3):243-8. [PMID:23670060]
-
(2013)
G Ital Dermatol Venereol
, vol.148
, Issue.3
, pp. 243-248
-
-
Gisondi, P.1
Girolomoni, G.2
-
33
-
-
77955921585
-
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
-
[PMID:20462664]
-
Langley RG, Feldman SR, Han C, Schenkel B, Szapary P, Hsu MC, Ortonne JP, Gordon KB, Kimball AB, Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol. 2010;63(3):457-65. [PMID:20462664]
-
(2010)
J Am Acad Dermatol
, vol.63
, Issue.3
, pp. 457-465
-
-
Langley, R.G.1
Feldman, S.R.2
Han, C.3
Schenkel, B.4
Szapary, P.5
Hsu, M.C.6
Ortonne, J.P.7
Gordon, K.B.8
Kimball, A.B.9
-
34
-
-
80855163580
-
Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: Results from PHOENIX 2
-
[PMID:21034290]
-
Reich K, Schenkel B, Zhao N, Szapary P, Augustin M, Bourcier M, Guenther L, Langley RG. Ustekinumab decreases work limitations, improves work productivity, and reduces work days missed in patients with moderate-to-severe psoriasis: results from PHOENIX 2. J Dermatolog Treat. 2011;22(6):337-47. [PMID:21034290]
-
(2011)
J Dermatolog Treat
, vol.22
, Issue.6
, pp. 337-347
-
-
Reich, K.1
Schenkel, B.2
Zhao, N.3
Szapary, P.4
Augustin, M.5
Bourcier, M.6
Guenther, L.7
Langley, R.G.8
-
35
-
-
77950594947
-
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial
-
[PMID:20219265]
-
Menter A, Augustin M, Signorovitch J, Yu AP, Wu EQ, Gupta SR, Bao Y, Mulani P. The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial. J Am Acad Dermatol. 2010;62(5):812-18. [PMID:20219265]
-
(2010)
J Am Acad Dermatol
, vol.62
, Issue.5
, pp. 812-818
-
-
Menter, A.1
Augustin, M.2
Signorovitch, J.3
Yu, A.P.4
Wu, E.Q.5
Gupta, S.R.6
Bao, Y.7
Mulani, P.8
-
36
-
-
84855827132
-
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis
-
[PMID:21616560]
-
Kimball AB, Yu AP, Signorovitch J, Xie J, Tsaneva M, Gupta SR, Bao Y, Mulani PM. The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. J Am Acad Dermatol. 2012;66(2):e67-76. [PMID:21616560]
-
(2012)
J Am Acad Dermatol
, vol.66
, Issue.2
-
-
Kimball, A.B.1
Yu, A.P.2
Signorovitch, J.3
Xie, J.4
Tsaneva, M.5
Gupta, S.R.6
Bao, Y.7
Mulani, P.M.8
-
37
-
-
84859073115
-
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis
-
[PMID:22455413]
-
Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, Braun D, Banerjee S. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med. 2012;366(13):1190-9. [PMID:22455413]
-
(2012)
N Engl J Med
, vol.366
, Issue.13
, pp. 1190-1199
-
-
Leonardi, C.1
Matheson, R.2
Zachariae, C.3
Cameron, G.4
Li, L.5
Edson-Heredia, E.6
Braun, D.7
Banerjee, S.8
-
38
-
-
84859017988
-
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis
-
[PMID:22455412]
-
Papp KA, Leonardi C, Menter A, Ortonne JP, Krueger JG, Kricorian G, Aras G, Li J, Russell CB, Thompson EH, Baumgartner S. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012;366(13):1181-9. [PMID:22455412]
-
(2012)
N Engl J Med
, vol.366
, Issue.13
, pp. 1181-1189
-
-
Papp, K.A.1
Leonardi, C.2
Menter, A.3
Ortonne, J.P.4
Krueger, J.G.5
Kricorian, G.6
Aras, G.7
Li, J.8
Russell, C.B.9
Thompson, E.H.10
Baumgartner, S.11
-
39
-
-
84896088319
-
Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: Use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory
-
[PMID:24079852]
-
Gordon KB, Kimball AB, Chau D, Viswanathan HN, Li J, Revicki DA, Kricorian G, Ortmeier BG. Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory. Br J Dermatol. 2014;170(3):705-15. [PMID:24079852]
-
(2014)
Br J Dermatol
, vol.170
, Issue.3
, pp. 705-715
-
-
Gordon, K.B.1
Kimball, A.B.2
Chau, D.3
Viswanathan, H.N.4
Li, J.5
Revicki, D.A.6
Kricorian, G.7
Ortmeier, B.G.8
-
40
-
-
84873124241
-
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study
-
[PMID:23106107]
-
Papp KA, Langley RG, Sigurgeirsson B, Abe M, Baker DR, Konno P, Haemmerle S, Thurston HJ, Papavassilis C, Richards HB. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study. Br J Dermatol. 2013;168(2):412-21. [PMID:23106107]
-
(2013)
Br J Dermatol
, vol.168
, Issue.2
, pp. 412-421
-
-
Papp, K.A.1
Langley, R.G.2
Sigurgeirsson, B.3
Abe, M.4
Baker, D.R.5
Konno, P.6
Haemmerle, S.7
Thurston, H.J.8
Papavassilis, C.9
Richards, H.B.10
-
41
-
-
84873168729
-
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase II regimen-finding study
-
[PMID:23362969]
-
Rich P, Sigurgeirsson B, Thaci D, Ortonne JP, Paul C, Schopf RE, Morita A, Roseau K, Harfst E, Guettner A, Machacek M,Papavassilis C. Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study. Br J Dermatol. 2013;168(2):402-11. [PMID:23362969]
-
(2013)
Br J Dermatol
, vol.168
, Issue.2
, pp. 402-411
-
-
Rich, P.1
Sigurgeirsson, B.2
Thaci, D.3
Ortonne, J.P.4
Paul, C.5
Schopf, R.E.6
Morita, A.7
Roseau, K.8
Harfst, E.9
Guettner, A.10
Machacek, M.11
Papavassilis, C.12
-
42
-
-
84885935651
-
Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: Findings from the National Psoriasis Foundation surveys, 2003-2011
-
[PMID:23945732]
-
Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol. 2013;149(10):1180-5. [PMID:23945732]
-
(2013)
JAMA Dermatol
, vol.149
, Issue.10
, pp. 1180-1185
-
-
Armstrong, A.W.1
Robertson, A.D.2
Wu, J.3
Schupp, C.4
Lebwohl, M.G.5
-
43
-
-
84900471388
-
Identifying individual psychosocial and adherence support needs in patients with psoriasis: A multinational two-stage qualitative and quantitative study
-
[PMID:23663069]
-
Bewley A, Burrage DM, Ersser SJ, Hansen M, Ward C. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study. J Eur Acad Dermatol Venereol. 2014;28(6):763-70. [PMID:23663069]
-
(2014)
J Eur Acad Dermatol Venereol
, vol.28
, Issue.6
, pp. 763-770
-
-
Bewley, A.1
Burrage, D.M.2
Ersser, S.J.3
Hansen, M.4
Ward, C.5
-
44
-
-
84881564770
-
Satisfaction with treatment among patients with psoriasis: A web-based survey study
-
[PMID:23565643]
-
van Cranenburgh OD, de Korte J, Sprangers MA, de Rie MA, Smets EM. Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol. 2013;169(2):398-405. [PMID:23565643]
-
(2013)
Br J Dermatol
, vol.169
, Issue.2
, pp. 398-405
-
-
van Cranenburgh, O.D.1
de Korte, J.2
Sprangers, M.A.3
de Rie, M.A.4
Smets, E.M.5
-
45
-
-
46449094084
-
The impact of physical illness on sexual dysfunction
-
[PMID:18391558]
-
Clayton A, Ramamurthy S. The impact of physical illness on sexual dysfunction. Adv Psychosom Med. 2008;2970-88. [PMID:18391558]
-
(2008)
Adv Psychosom Med
, pp. 2970-2988
-
-
Clayton, A.1
Ramamurthy, S.2
-
46
-
-
77949506527
-
Provider-initiated pay-for-performance in a clinically integrated hospital network
-
[PMID:20151591]
-
Atkinson JG, Masiulis KE, Felgner L, Schumacher DN. Provider-initiated pay-for-performance in a clinically integrated hospital network. J Healthc Qual. 2010;32(1):42-50. [PMID:20151591]
-
(2010)
J Healthc Qual
, vol.32
, Issue.1
, pp. 42-50
-
-
Atkinson, J.G.1
Masiulis, K.E.2
Felgner, L.3
Schumacher, D.N.4
-
47
-
-
79955102875
-
Patient satisfaction in pay for performance programs
-
[PMID:21467898]
-
Press I, Fullam F. Patient satisfaction in pay for performance programs. Qual Manag Health Care. 2011;20(2):110-5. [PMID:21467898]
-
(2011)
Qual Manag Health Care
, vol.20
, Issue.2
, pp. 110-115
-
-
Press, I.1
Fullam, F.2
-
48
-
-
79952517218
-
Why measure patient satisfaction?
-
[PMID:21506460]
-
Riskind P, Fossey L, Brill K. Why measure patient satisfaction? J Med Pract Manage. 2011;26(4):217-20. [PMID:21506460]
-
(2011)
J Med Pract Manage
, vol.26
, Issue.4
, pp. 217-220
-
-
Riskind, P.1
Fossey, L.2
Brill, K.3
-
49
-
-
85028151954
-
Patient satisfaction Implications and predictors of success
-
[PMID:23677370]
-
Shirley ED, Sanders JO. Patient satisfaction: Implications and predictors of success. J Bone Joint Surg Am. 2013;95(10):e69. [PMID:23677370]
-
(2013)
J Bone Joint Surg Am
, vol.95
, Issue.10
-
-
Shirley, E.D.1
Sanders, J.O.2
-
50
-
-
84982887005
-
-
Agency For Healthcare Research and Quality Accessed March10, 2014Available at
-
CAHPS®: Consumer Assessment of Healthcare Providers and Systems. Agency for Healthcare Research and Quality. 2013. Available at: https://cahps.ahrq.gov/. Accessed March 10, 2014.
-
(2013)
CAHPS®: Consumer Assessment of Healthcare Providers and Systems
-
-
-
51
-
-
84898734214
-
-
Centers For Medicare & Medicaid Services Available at, Accessed March 10, 2014
-
Medicare.gov. Hospital Compare. Centers for Medicare & Medicaid Services. Available at: www.medicare.gov/hospitalcompare. Accessed March 10, 2014.
-
Medicare.gov. Hospital Compare
-
-
-
53
-
-
84906271765
-
Physician quality measure reporting
-
Available at, Accessed March 10, 2014
-
Physician quality measure reporting. American Medical Associatio n. Available at: http://www.ama-assn.org/ama/pub/physician-resources/clinical-practice-improvement/clinical-quality/physician-quality-reporting-system.page. Accessed March 10, 2014.
-
American Medical Associatio N
-
-
-
54
-
-
84898734214
-
-
Centers For Medicare & Medicaid Services Available at, Accessed March 10, 2014
-
Medicare.gov. Physician Compare. Centers for Medicare & Medicaid Services. Available at: www.medicare.gov/physiciancompare. Accessed March 10, 2014.
-
Medicare.gov. Physician Compare
-
-
|